We collect analytics data in order to understand site usage. This data is collected anonymously and is not associated to you personally. Decide what you want to share with us below.
Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.